Biocept, Potential Near-Term Catalysts for Biocept

ACCESSWIRE

Mon, Mar 18, 2019, 8:00 AM

NEW YORK, NY / ACCESSWIRE / March 18, 2019 / Traders News Source, a leading independent equity research and corporate access firm focused on small and mid-cap public companies is issuing a comprehensive report on Biocept, Inc. (BIOC), an early stage molecular oncology diagnostics company that develops and commercializes proprietary circulating tumor cell (CTC) and circulating tumor DNA assays utilizing a standard blood sample.

BIOC has expanded its pathology partnership platform, EmpowerTCTM, to now offer local pathologists the ability to analyze prognostic and predictive markers on CTCs from a liquid biopsy using immunocytochemistry (ICC) methods.

Our comprehensive report covers potential near-term catalysts for BIOC READ MORE

Copy and paste to your browser may be required to view the report - https://tradersnewssource.com/biocept-2/

CEE-Sure™ BCT utilizes patented technology (Patent US9040255) that improves cell capture in a microchannel, inhibiting cell clumping and clogging of microfluidic devices. The blood collection tube is designed to prevent blood coagulation and preserve cells from lysing due to age or transport conditions. CEE-Sure™ allows for room temperature shipment of whole blood for nucleated cell isolation and cfDNA detection.

Get the analysts opinions, product overview and financial data in this comprehensive report READ MORE

Copy and paste to your browser may be required to view the report - https://tradersnewssource.com/biocept-2/

This document is not intended as an offering, recommendation, or a solicitation of an offer to buy or sell the securities mentioned or discussed and is to be used for informational purposes only. Please read all associated disclosures and disclaimers in full before investing. Neither TNS nor any party affiliated with us is a registered investment adviser or broker-dealer with any agency or in any jurisdiction whatsoever. To download our report(s), read our disclosures, or for more information, visit https://www.tradersnewssource.com.

CFA® and Chartered Financial Analyst® are registered trademarks owned by CFA Institute.

CONTACT: editor@tradersnewssource.com

SOURCE: Traders News Source

View source version on accesswire.com:
https://www.accesswire.com/539322/Biocept-Potential-Near-Term-Catalysts-for-Biocept

Suze Orman Decided To Drop Homeowners Insurance After An Outrageous Quote: '$28,000 For A 2,100-Square-Foot Condo. Are You Kidding Me?'
Finance expert Suze Orman has voiced concerns about the impact of climate change on property insurance costs, asserting it could threaten the American dream of homeownership. Orman, 72, faced a $28,000 annual insurance quote for her Florida oceanside condo, leading her to forego coverage entirely. She highlights a troubling trend where soaring insurance costs driven by frequent and severe weather events may deter Americans from buying homes. Don't Miss: For many first-time buyers, a house is abo
Benzinga•6h ago
The IRS says it’s going after wealthy tax cheats. Here’s what new audit stats show.
After Congress approved billions of extra funding for tax compliance, the Internal Revenue Service pledged it would get tougher on rich taxpayers and corporations while avoiding extra scrutiny of middle-class households.
MarketWatch•9h ago
Advanced Micro Devices (AMD) Expected to Beat Earnings Estimates: Can the Stock Move Higher?
Advanced Micro (AMD) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Zacks•9h ago
JPMorgan’s ‘Bloody Friday’: Why Several Top Financial Advisors Jumped Ship the Same Day
Six teams managing nearly $15 billion in total assets quit JPMorgan Chase’s brokerage unit to join competitors last Friday. Here’s what may have triggered their departures.
Barrons.com•5h ago
Tesla Earnings Fall To Lowest Since 2021. Tesla Stock Surges Late On 'Affordable' EV.
Tesla earnings tumbled below lowered expectations. Tesla stock jumped late as the EV giant signaled an affordable EV is still it its plans. Elon Musk looms.
Investor's Business Daily•49m ago
Cathie Wood's Ark Empire Bleeds As Investor Outflows Spike: 'The Loyal Shareholders Have Become Frustrated'
In early 2021, Ark Invest, led by tech investor Cathie Wood, managed a staggering $59 billion across six funds, making it the world’s largest active ETF manager. Three years later, a significant 80% downturn occurred, with assets under management in those funds plummeting to just $11.1 billion. This decline can be attributed to a combination of factors, including high interest rates dampening Wood’s long-term speculative tech investments and the subsequent wave of outflows from disillusioned inv
Benzinga•4h ago
Ex-Googler and Palestinian-American fired for opposing Project Nimbus speaks out: ‘This was not my idea of what the American workplace should be’
Several fired Google employees spoke at a press conference Monday about their experiences.
Fortune•8h ago
Holding 6 Ethereum (ETH) Could Make You A Millionaire, According to Cathie Wood
With the recent halving and spot exchange-traded funds (ETFs) driving demand, Bitcoin has had the spotlight for much of 2024. However, according to Cathie Wood of Ark Invest, Ethereum (ETH) could catch up to Bitcoin and provide investors with huge profits in the coming years. At an investor conference held by Ark Invest, Wood spoke about Ethereum, noting that the project could reach a market capitalization of $20 trillion by 2032. ETH currently has a supply of around 120 million tokens. So, a ma
Benzinga•9h ago
California McDonald's Franchise Owner Says, 'The Focus Is On Survival' With 'Unprecedented' $20 Per Hour Minimum Wage Forcing Higher Prices
In response to California's new $20 minimum wage law, fast food franchises are being forced to rethink their business strategies to stay afloat. Scott Rodrick, who owns 18 McDonald's franchises in the state, is considering measures to manage the increased labor costs without resorting to layoffs, which he sees as a last resort. Don't Miss: 82% of Americans aren’t using this government secured 5% passive income stream, are you one of them? The average American couple has saved this much money for
Benzinga•1d ago
It's Time to Ditch These 2 "Magnificent Seven" Stocks and Replace Them With 2 Bona Fide Outperformers
Among Microsoft, Apple, Nvidia, Alphabet, Amazon, Meta Platforms, and Tesla, there are two former highfliers that are no longer magnificent.
Motley Fool•2d ago

News

Life

Entertainment

Finance

Sports

New on Yahoo

Yahoo Finance

Biocept, Potential Near-Term Catalysts for Biocept

Recommended Stories

Suze Orman Decided To Drop Homeowners Insurance After An Outrageous Quote: '$28,000 For A 2,100-Square-Foot Condo. Are You Kidding Me?'

The IRS says it’s going after wealthy tax cheats. Here’s what new audit stats show.

Advanced Micro Devices (AMD) Expected to Beat Earnings Estimates: Can the Stock Move Higher?

JPMorgan’s ‘Bloody Friday’: Why Several Top Financial Advisors Jumped Ship the Same Day

Tesla Earnings Fall To Lowest Since 2021. Tesla Stock Surges Late On 'Affordable' EV.

Cathie Wood's Ark Empire Bleeds As Investor Outflows Spike: 'The Loyal Shareholders Have Become Frustrated'

Ex-Googler and Palestinian-American fired for opposing Project Nimbus speaks out: ‘This was not my idea of what the American workplace should be’

Holding 6 Ethereum (ETH) Could Make You A Millionaire, According to Cathie Wood

California McDonald's Franchise Owner Says, 'The Focus Is On Survival' With 'Unprecedented' $20 Per Hour Minimum Wage Forcing Higher Prices

It's Time to Ditch These 2 "Magnificent Seven" Stocks and Replace Them With 2 Bona Fide Outperformers